BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7987490)

  • 1. Simultaneous determination of plasma haloperidol and its metabolite reduced haloperidol by liquid chromatography with electrochemical detection. Plasma levels in schizophrenic patients treated with oral or intramuscular depot haloperidol.
    Aravagiri M; Marder SR; Van Putten T; Marshall BD
    J Chromatogr B Biomed Appl; 1994 Jun; 656(2):373-81. PubMed ID: 7987490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical loading dose method for converting schizophrenic patients from oral to depot haloperidol therapy.
    Wei FC; Jann MW; Lin HN; Piao-Chien C; Chang WH
    J Clin Psychiatry; 1996 Jul; 57(7):298-302. PubMed ID: 8666571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved sensitive assay for simultaneous determination of plasma haloperidol and reduced haloperidol levels by liquid chromatography using a coulometric detector.
    Hariharan M; Kindt EK; VanNoord T; Tandon R
    Ther Drug Monit; 1989 Nov; 11(6):701-7. PubMed ID: 2595753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of haloperidol and its reduced metabolite in serum and plasma by isocratic liquid chromatography with electrochemical detection.
    Korpi ER; Phelps BH; Granger H; Chang WH; Linnoila M; Meek JL; Wyatt RJ
    Clin Chem; 1983 Apr; 29(4):624-8. PubMed ID: 6831688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of risperidone in plasma by high-performance liquid chromatography with electrochemical detection: application to therapeutic drug monitoring in schizophrenic patients.
    Aravagiri M; Marder SR; Van Putten T; Midha KK
    J Pharm Sci; 1993 May; 82(5):447-9. PubMed ID: 7689651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Megabore capillary gas-liquid chromatographic method with nitrogen-phosphorus selective detection for the assay of haloperidol and reduced haloperidol in serum: results of therapeutic drug-monitoring during acute therapy of eight schizophrenics.
    Ulrich S; Meyer FP; Neuhof S; Knorr W
    J Chromatogr B Biomed Appl; 1995 Jan; 663(2):289-96. PubMed ID: 7735476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of reduced haloperidol and haloperidol by radioimmunoassay.
    Browning JL; Harrington CA; Davis CM
    J Immunoassay; 1985; 6(1-2):45-66. PubMed ID: 4019788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of risperidone and its 9-hydroxy metabolite and their relationship to dose in schizophrenic patients: simultaneous determination by a high performance liquid chromatography with electrochemical detection.
    Aravagiri M; Marder SR; Wirshing D; Wirshing WC
    Pharmacopsychiatry; 1998 May; 31(3):102-9. PubMed ID: 9657237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A loading-dose strategy for converting from oral to depot haloperidol.
    Ereshefsky L; Toney G; Saklad SR; Anderson C; Seidel D
    Hosp Community Psychiatry; 1993 Dec; 44(12):1155-61. PubMed ID: 7907570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology, pharmacokinetics and clinical development of haloperidol decanoate.
    Gelders YG
    Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():1-11. PubMed ID: 3559159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An ultrasensitive method for the measurement of haloperidol and reduced haloperidol in plasma by high-performance liquid chromatography with coulometric detection.
    Midha KK; Cooper JK; Hawes EM; Hubbard JW; Korchinski ED; McKay G
    Ther Drug Monit; 1988; 10(2):177-83. PubMed ID: 3381235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.
    Eyles DW; Whiteford HA; Stedman TJ; Pond SM
    Psychopharmacology (Berl); 1992; 106(2):268-74. PubMed ID: 1549652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two high-performance liquid chromatographic methods for monitoring plasma concentrations of haloperidol and reduced haloperidol.
    Pan L; Rosseel MT; Belpaire FM
    Ther Drug Monit; 1998 Apr; 20(2):224-30. PubMed ID: 9558139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
    Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioavailability and pharmacokinetics of oral and depot intramuscular haloperidol in schizophrenic patients.
    Nayak RK; Doose DR; Nair NP
    J Clin Pharmacol; 1987 Feb; 27(2):144-50. PubMed ID: 3680566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of haloperidol and its reduced metabolite in human plasma by liquid chromatography-mass spectrometry with electrospray ionization.
    Hoja H; Marquet P; Verneuil B; Lotfi H; Dupuy JL; Pénicaut B; Lachâtre G
    J Chromatogr B Biomed Sci Appl; 1997 Jan; 688(2):275-80. PubMed ID: 9061465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitive electrochemical high-performance liquid chromatography assay for the simultaneous determination of haloperidol and reduced haloperidol.
    Eddington ND; Young D
    J Pharm Sci; 1988 Jun; 77(6):541-3. PubMed ID: 3171937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of haloperidol and reduced haloperidol in human serum by liquid chromatography after fluorescence labeling based on the Suzuki coupling reaction.
    Kishikawa N; Hamachi C; Imamura Y; Ohba Y; Nakashima K; Tagawa Y; Kuroda N
    Anal Bioanal Chem; 2006 Oct; 386(3):719-24. PubMed ID: 16957915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial comparing intramuscular haloperidol decanoate and oral haloperidol in chronic schizophrenic patients: efficacy, safety, and dosage equivalence.
    Vasavan Nair NP; Suranyi-Cadotte B; Schwartz G; Thavundayil JX; Achim A; Lizondo E; Nayak R
    J Clin Psychopharmacol; 1986 Feb; 6(1 Suppl):30S-37S. PubMed ID: 3514689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma level monitoring of olanzapine in patients with schizophrenia: determination by high-performance liquid chromatography with electrochemical detection.
    Aravagiri M; Ames D; Wirshing WC; Marder SR
    Ther Drug Monit; 1997 Jun; 19(3):307-13. PubMed ID: 9200772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.